Chirag Talati, analyst at Espirito Santo Securities Pharma, in an interview with CNBC-TV18's Sonia Shenoy and Anuj Singhal, gave his perspective on the Glenmark-Sanofi deal and why he is bearish on Dr Reddy's and Ranbaxy.
first published: May 17, 2011 03:02 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

